Interview with Peter Pang: Where Biosimilar CMC Risk Really Sits Today
Article Date
March 2, 2026
This article is featured on another website.
Go to article
January 29, 2026
Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company
Overview A US biotech company's Phase I oncology study had stalled under the management of…
January 29, 2026
Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company
Overview A US biotech company's Phase I oncology study had stalled under the management of…